As WHO, CEPI, and Gavi meet and consider how best to manage the planning and deployment of a COVID-19 vaccine, we feel the voice of older adults, one of the most vulnerable, important, and essential groups should feature prominently in the COVAX process.

New York, NEW YORK (July 14, 2020) – The American Federation for Aging Research (AFAR) and the Global Coalition on Aging today released a report, Adult Vaccinations: Opportunities for Action, Barriers to Engagement, Paths to Healthier Aging. The new report shares insights from an expert symposium hosted by the two organizations in late 2019 on the urgency of vaccinations for adults to promote healthy aging.

New York, NEW YORK (November 19, 2019) – The Global Coalition on Aging (GCOA) and Pfizer Global Medical Grants today officially launched a partnership to improve uptake of vaccines among Japanese older adults. Through $1 million USD in grant awards, the Vaccines for All: Longevity Unleashed for Everyone (VALUE) initiative will support, advance, and validate quality improvement strategies that measurably increase the number of older adults in Japan who are immunized against at least one targeted vaccine-preventable disease.

New York, NEW YORK (November 14, 2019) – Today, the Global Coalition on Aging (GCOA) is launching the Global Alliance on Heart Failure and Healthy Aging (the Alliance), recognizing that while heart failure does increase in prevalence with age, it is not a normal part of aging.

New York, NEW YORK (October 25, 2019) – On Wednesday night, the Global Coalition on Aging (GCOA), the United Nations Department for Economic and Social Affairs (UN DESA), and the Permanent Mission of Antigua and Barbuda to the United Nations, along with three leading organizations addressing vision loss, brought together more than 60 United Nations (UN) ambassadors and leaders from global nongovernmental organizations for an immersive dining experience directly connecting the growing numbers of people who are visually impaired with the 21st century megatrend of aging.